temozolomide has been researched along with Brill-Symmers Disease in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The KNOG-1101 study showed improved 2-year PFS with temozolomide during and after radiotherapy compared to radiotherapy alone for patients with anaplastic gliomas." | 9.51 | Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study). ( Ahn, GS; Chang, JH; Choe, G; Choi, BS; Hong, YK; Hwang, K; Joo, J; Jung, TY; Kang, SG; Kim, CY; Kim, EY; Kim, JH; Kim, SH; Kim, TM; Kim, YJ; Lee, DE; Nam, DH; Park, CK; Yoo, H, 2022) |
| "The KNOG-1101 study showed improved 2-year PFS with temozolomide during and after radiotherapy compared to radiotherapy alone for patients with anaplastic gliomas." | 5.51 | Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study). ( Ahn, GS; Chang, JH; Choe, G; Choi, BS; Hong, YK; Hwang, K; Joo, J; Jung, TY; Kang, SG; Kim, CY; Kim, EY; Kim, JH; Kim, SH; Kim, TM; Kim, YJ; Lee, DE; Nam, DH; Park, CK; Yoo, H, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jo, J | 1 |
| Schiff, D | 1 |
| Ahn, GS | 1 |
| Hwang, K | 1 |
| Kim, TM | 1 |
| Park, CK | 1 |
| Chang, JH | 1 |
| Jung, TY | 1 |
| Kim, JH | 2 |
| Nam, DH | 1 |
| Kim, SH | 1 |
| Yoo, H | 1 |
| Hong, YK | 1 |
| Kim, EY | 1 |
| Lee, DE | 1 |
| Joo, J | 1 |
| Kim, YJ | 1 |
| Choe, G | 1 |
| Choi, BS | 1 |
| Kang, SG | 1 |
| Kim, CY | 1 |
1 review available for temozolomide and Brill-Symmers Disease
| Article | Year |
|---|---|
Current Considerations in the Treatment of Grade 3 Gliomas.
Topics: Astrocytoma; Brain Neoplasms; Glioma; Humans; Isocitrate Dehydrogenase; Lymphoma, Follicular; Mutati | 2022 |
1 trial available for temozolomide and Brill-Symmers Disease
| Article | Year |
|---|---|
Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study).
Topics: Brain Neoplasms; Chemoradiotherapy; Glioma; Humans; Lymphoma, Follicular; Quality of Life; Temozolom | 2022 |